Document is current
Any future updates will be listed below
-
Authors
Oguri, Noriaki
Miyoshi, Jun
Nishinarita, Yuu
Wada, Haruka
Nemoto, Nobuki
Hibi, Noritaka
Kawamura, Naohiro
Miyoshi, Sawako https://orcid.org/0009-0008-8927-4417
Lee, Sonny T. M. https://orcid.org/0000-0001-8073-989X
Matsuura, Minoru
Osaki, Takako https://orcid.org/0000-0002-6430-4666
Hisamatsu, Tadakazu https://orcid.org/0000-0002-1178-3536
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (20K08339, 23K07360)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 2 September 2024
First Online: 16 September 2024
Competing interests
: J.M. has received grant support from AbbVie GK; and received consulting and lecture fees from EA Pharma Co., Ltd, AbbVie GK, Janssen Pharmaceutical K.K., Jansen Asia Pacific Pte. Ltd, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co., Ltd, and Takeda Pharmaceutical Co., Ltd. M.M. has received consulting and lecture fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co., Ltd, AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co., Ltd, Mochida Pharmaceutical Co., Ltd, JIMRO Co., Nippon Kayaku Co., Ltd, Mylan EPD G.K., and Aspen Japan Co., Ltd. T.H. has performed Joint Research with Alfresa Pharma Co., Ltd, and EA Pharma Co., Ltd; received grant support from AbbVie GK, Boston Scientific Corp., EA Pharma Co., Ltd, JIMRO Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd, Nippon Kayaku Co., Ltd, Pfizer Inc., and Takeda Pharmaceutical Co., Ltd, and received consulting and lecture fees from AbbVie GK, EA Pharma Co., Ltd, Janssen Research & Development, LLC., Gilead Sciences Inc., Eli Lilly and Co., Bristol Myers Squibb, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd, Mochida Pharmaceutical Co., Ltd, and Kissei Pharmaceutical Co., Ltd. All other authors declare no financial or non-financial competing interests.
